Expression of Adhesion Molecule CD56 in Tumor Plasma Cells in Bone Marrow as a Prognostic Factor in Multiple Myeloma
Savchenko Vg(National Research Center for Hematology Russian Academy of Medical Sciences), А. М. Ковригина(Shupyk National Healthcare University of Ukraine), Л. П. Менделеева(National Research Center for Hematology Russian Academy of Medical Sciences), Mikhail Drokov(National Research Center for Hematology Russian Academy of Medical Sciences), N. L. Deineko(National Medical Research Center for Hematology), M. V. Solovev(Ministry of Health of the Russian Federation)
Cited by 5
Related Papers
Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation
|Bone Marrow Transplantation|2014|195
Atlas of RNA sequencing profiles for normal human tissues
|Scientific Data|2019|142
Current Multiple Myeloma Treatment Strategies with Novel Agents: A European Perspective
|The Oncologist|2010|92
Thromboelastography, thrombin generation test and thrombodynamics reveal hypercoagulability in patients with multiple myeloma
|Leukemia & lymphoma/Leukemia and lymphoma|2015|59